The Decreased Growth Hormone Response to Growth Hormone Releasing Hormone in Obesity Is Associated to Cardiometabolic Risk Factors

The aim of the present study was to evaluate the relationship between GHRH-induced GH secretion in obese premenopausal women and cardiovascular risk markers or insulin resistance. Premenopausal obese women, aged 35–52 years, were studied. GH secretion, IGF-I, serum cardiovascular risk markers, insul...

Full description

Saved in:
Bibliographic Details
Main Authors: Fernando Cordido, Jesús Garcia-Buela, Susana Sangiao-Alvarellos, Teresa Martinez, Ovidio Vidal
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2010/434562
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564183565074432
author Fernando Cordido
Jesús Garcia-Buela
Susana Sangiao-Alvarellos
Teresa Martinez
Ovidio Vidal
author_facet Fernando Cordido
Jesús Garcia-Buela
Susana Sangiao-Alvarellos
Teresa Martinez
Ovidio Vidal
author_sort Fernando Cordido
collection DOAJ
description The aim of the present study was to evaluate the relationship between GHRH-induced GH secretion in obese premenopausal women and cardiovascular risk markers or insulin resistance. Premenopausal obese women, aged 35–52 years, were studied. GH secretion, IGF-I, serum cardiovascular risk markers, insulin, leptin, mid-waist and hip circumference, total body fat, and truncal fat were measured. Subjects were classified as meeting the criteria for GH deficiency (GHD) when peak GH after stimulation with GHRH was ≤3 μg/L. Mean total and LDL cholesterol, fasting insulin, and HOMA-IR were all higher, in subjects who would have been classified as GH-deficient compared with GH-sufficient. Peak GH secretion after stimulation was inversely associated with fasting insulin (R=−0.650, P=.012), HOMA-IR (R=−0.846, P=.001), total cholesterol (R=−0.532, P=.034), and LDL cholesterol (R=−0.692, P=.006) and positively associated with HDL cholesterol (R=0.561, P=.037). These data strongly suggest a role for insulin resistance in the decreased GH secretion of obesity and that the blunted GH secretion of central obesity could be the pituitary expression of the metabolic syndrome.
format Article
id doaj-art-372a4a0da6214864b5d14da6ade4bbdc
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2010-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-372a4a0da6214864b5d14da6ade4bbdc2025-02-03T01:11:38ZengWileyMediators of Inflammation0962-93511466-18612010-01-01201010.1155/2010/434562434562The Decreased Growth Hormone Response to Growth Hormone Releasing Hormone in Obesity Is Associated to Cardiometabolic Risk FactorsFernando Cordido0Jesús Garcia-Buela1Susana Sangiao-Alvarellos2Teresa Martinez3Ovidio Vidal4Department of Endocrinology, Hospital A Coruña, 15006 A Coruña, SpainDepartment of Laboratory, Hospital A Coruña, 15006 A Coruña, SpainDepartment of Investigation, Hospital A Coruña, 15006 A Coruña, SpainDepartment of Endocrinology, Hospital A Coruña, 15006 A Coruña, SpainDepartment of Endocrinology, Hospital A Coruña, 15006 A Coruña, SpainThe aim of the present study was to evaluate the relationship between GHRH-induced GH secretion in obese premenopausal women and cardiovascular risk markers or insulin resistance. Premenopausal obese women, aged 35–52 years, were studied. GH secretion, IGF-I, serum cardiovascular risk markers, insulin, leptin, mid-waist and hip circumference, total body fat, and truncal fat were measured. Subjects were classified as meeting the criteria for GH deficiency (GHD) when peak GH after stimulation with GHRH was ≤3 μg/L. Mean total and LDL cholesterol, fasting insulin, and HOMA-IR were all higher, in subjects who would have been classified as GH-deficient compared with GH-sufficient. Peak GH secretion after stimulation was inversely associated with fasting insulin (R=−0.650, P=.012), HOMA-IR (R=−0.846, P=.001), total cholesterol (R=−0.532, P=.034), and LDL cholesterol (R=−0.692, P=.006) and positively associated with HDL cholesterol (R=0.561, P=.037). These data strongly suggest a role for insulin resistance in the decreased GH secretion of obesity and that the blunted GH secretion of central obesity could be the pituitary expression of the metabolic syndrome.http://dx.doi.org/10.1155/2010/434562
spellingShingle Fernando Cordido
Jesús Garcia-Buela
Susana Sangiao-Alvarellos
Teresa Martinez
Ovidio Vidal
The Decreased Growth Hormone Response to Growth Hormone Releasing Hormone in Obesity Is Associated to Cardiometabolic Risk Factors
Mediators of Inflammation
title The Decreased Growth Hormone Response to Growth Hormone Releasing Hormone in Obesity Is Associated to Cardiometabolic Risk Factors
title_full The Decreased Growth Hormone Response to Growth Hormone Releasing Hormone in Obesity Is Associated to Cardiometabolic Risk Factors
title_fullStr The Decreased Growth Hormone Response to Growth Hormone Releasing Hormone in Obesity Is Associated to Cardiometabolic Risk Factors
title_full_unstemmed The Decreased Growth Hormone Response to Growth Hormone Releasing Hormone in Obesity Is Associated to Cardiometabolic Risk Factors
title_short The Decreased Growth Hormone Response to Growth Hormone Releasing Hormone in Obesity Is Associated to Cardiometabolic Risk Factors
title_sort decreased growth hormone response to growth hormone releasing hormone in obesity is associated to cardiometabolic risk factors
url http://dx.doi.org/10.1155/2010/434562
work_keys_str_mv AT fernandocordido thedecreasedgrowthhormoneresponsetogrowthhormonereleasinghormoneinobesityisassociatedtocardiometabolicriskfactors
AT jesusgarciabuela thedecreasedgrowthhormoneresponsetogrowthhormonereleasinghormoneinobesityisassociatedtocardiometabolicriskfactors
AT susanasangiaoalvarellos thedecreasedgrowthhormoneresponsetogrowthhormonereleasinghormoneinobesityisassociatedtocardiometabolicriskfactors
AT teresamartinez thedecreasedgrowthhormoneresponsetogrowthhormonereleasinghormoneinobesityisassociatedtocardiometabolicriskfactors
AT ovidiovidal thedecreasedgrowthhormoneresponsetogrowthhormonereleasinghormoneinobesityisassociatedtocardiometabolicriskfactors
AT fernandocordido decreasedgrowthhormoneresponsetogrowthhormonereleasinghormoneinobesityisassociatedtocardiometabolicriskfactors
AT jesusgarciabuela decreasedgrowthhormoneresponsetogrowthhormonereleasinghormoneinobesityisassociatedtocardiometabolicriskfactors
AT susanasangiaoalvarellos decreasedgrowthhormoneresponsetogrowthhormonereleasinghormoneinobesityisassociatedtocardiometabolicriskfactors
AT teresamartinez decreasedgrowthhormoneresponsetogrowthhormonereleasinghormoneinobesityisassociatedtocardiometabolicriskfactors
AT ovidiovidal decreasedgrowthhormoneresponsetogrowthhormonereleasinghormoneinobesityisassociatedtocardiometabolicriskfactors